Open Access. Powered by Scholars. Published by Universities.®

Arts and Humanities Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 151 - 158 of 158

Full-Text Articles in Arts and Humanities

The Breast Cancer Research Scandal: Addressing The Issues, Charles Weijer Apr 1995

The Breast Cancer Research Scandal: Addressing The Issues, Charles Weijer

Charles Weijer

The three claims put forward by Dr. Roger Poisson to rationalize his enrollment of ineligible subjects in clinical trials do not justify research fraud. None the less, certain lessons for the conduct of clinical research can be learned from the affair: experimental therapies should be made available to technically ineligible subjects when no effective therapy exists for their disease; further research must investigate the possible benefits of clinical-trial participation; broadly based, pragmatic trials must be regarded as the ideal model; and each eligibility criterion in a clinical-trial protocol should be justified.


Pulling The Plug On Futility, Charles Weijer, Carl Elliott Mar 1995

Pulling The Plug On Futility, Charles Weijer, Carl Elliott

Charles Weijer

No abstract provided.


Biomedical Ethics In A Canadian Context, Charles Weijer Sep 1994

Biomedical Ethics In A Canadian Context, Charles Weijer

Charles Weijer

No abstract provided.


Momento Mori, Charles Weijer Apr 1994

Momento Mori, Charles Weijer

Charles Weijer

No abstract provided.


The Duty To Exclude: Excluding People At Undue Risk From Research, Charles Weijer, Abraham Fuks Mar 1994

The Duty To Exclude: Excluding People At Undue Risk From Research, Charles Weijer, Abraham Fuks

Charles Weijer

The clinical trial is the major investigational tool of clinical medicine. Two recent reports highlight the fact that the most often quoted mechanisms for the protection of research subjects, viz., research ethics board review and eligibility criteria, are insufficient to achieve this end. In this paper, we argue that the prime mechanism for the protection of persons in clinical trials should be the clinical judgement of the physician-investigator. The clinical investigator has a duty to protect subjects from both harm and undue risk. It is argued that the clinical investigator has a duty to screen for, and exclude, potential research …


Case Notes And Carting Of Bioethical Case Consultations, Benjamin Freedman, Charles Weijer, Eugene Bereza Apr 1993

Case Notes And Carting Of Bioethical Case Consultations, Benjamin Freedman, Charles Weijer, Eugene Bereza

Charles Weijer

In summary, the usual elements of a typical health care ethics consultation note might reasonably accommodate the needs and expectations of relevant parties, and would therefore include: 1. identification of the relevant ethical issues, questions, or dilemmas; 2. reference to any relevant facts--medical, nursing, social, psychological, spiritual, legal, political, etc.; 3. a prioritized list of recommendations to improve coordinated care; 4. a clear and concise articulation of relevant arguments, wtih specific reference to the list of recommendations as well as to the institution's overall ethos; 5. a contextual statement, identifying the perceived degree of consensus or support for the recommendations …


In Loco Parentis: Minimal Risk As An Ethical Threshold For Research Upon Children, Benjamin Freedman, Abraham Fuks, Charles Weijer Feb 1993

In Loco Parentis: Minimal Risk As An Ethical Threshold For Research Upon Children, Benjamin Freedman, Abraham Fuks, Charles Weijer

Charles Weijer

No abstract provided.


[Demarcating Research And Treatment Interventions: A Case Illustration]: Commentary, Benjamin Freedman, Charles Weijer Jun 1992

[Demarcating Research And Treatment Interventions: A Case Illustration]: Commentary, Benjamin Freedman, Charles Weijer

Charles Weijer

No abstract provided.